Latest Breaking News On - Jason zemansky - Page 1 : comparemela.com

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster

StockWatch: Insmed Shares Leap 150%, as Analysts See Next Blockbuster
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Jason zemanskyGoldman sachs andreaFargo tiago fauthMartina flammerTrung huynhStifel stephen willeyTreprostinil palmitilNicole germinoRegeneron pharmaceuticalsEuropean unionUs centers for diseaseNew drug applicationDisease controlLeerink partnersLeon wangAndrea tan

Travere Therapeutics, Inc (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript

Travere Therapeutics, Inc (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesJula inrigMaury raycroftEric dubeyWilliam blairAnupam ramaAnne crotteauTyler van burenCarter gouldDeric dubeJoseph schwartzTim lugoChris clineJason zemanskyPeter heermaMirum pharmaceuticals

Kura Oncology, Inc (NASDAQ:KURA) Q1 2024 Earnings Call Transcript

Operator: Good afternoon, ladies and gentlemen, and welcome to the Q1 2024 Kura Oncology Financial Results Conference Call. At this time, all participants are in listen-only mode.

United statesTom doyleJason zemanskyTroy wilsonBristol myers squibbThomas doyleJonathan changSafety monitoring committeeKura oncology incKura oncologyCall transcript mayOncology financial results conferencePete de spainFirst quarterChief executive officerSenior vice president

Cytokinetics, Incorporated (NASDAQ:CYTK) Q3 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome, ladies and gentlemen, to Cytokinetics Third Quarter 2023 Conference Call.

United statesUnited kingdomRobert wongSalim syedDiane weiserRobert blumJoe pantginisJason zemanskyFady malikJi xingDane leoneCameron rosaAndrew callosStuart kupferOffice of new drugsAmerican college of cardiology

Bank of America Says Contrarian Buy Signal Could Push Stocks Higher; Here Are 2 Names the Banking Giant Likes Right Now

Investors have had little to cheer about recently as the markets have struggled to shake off the grip of various factors pulling them down. These factors include the prospect of interest rates remaining elevated, concerns related to high yield bonds, an uptick in oil prices, and the ongoing conflict between Israel and the terrorist organization Hamas, all of which have played a role in dampening market activity. However, for investors seeking signs that the mood is about to change, Bank of Ameri

United statesCurtis nagleBernard kimJason zemanskySyndax pharmaceuticalsBear indicatorTime oncology reviewNew drug applicationBiologics licensing applicationWall streetStrong buyModerate buyBest stocksBank of americaSyndax pharmaceuticalsStrong buy